Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 9—September 2024
Research

Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015–2019

Shihwan Chang1, Sol Kim1, Young Ae Kang, Moo Suk Park, Hojoon Sohn2, and Youngmok Park2Comments to Author 
Author affiliations: Yonsei University College of Medicine, Seoul, South Korea (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Severance Hospital, Seoul (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Seoul National University College of Medicine, Seoul (H. Sohn); Seoul National University Institute of Health Policy and Management, Seoul (H. Sohn)

Main Article

Table 3

Cost analysis of the treatment of nontuberculous mycobacterial pulmonary disease, South Korea, 2015–2019*

Variable Median costs (interquartile range)
Cumulative† Out-of-pocket Annual‡ Per visit§
All visits, n = 147
Total 5,044 (3,586–9,680) 2,535 (1,779–4,087) 1,319 (845–2,478) NA
Nonbenefit 115 (13–431) 115 (13–497) 28 (3–109) NA
Medication 1,197 (656–2,728) 362 (214–872) 296 (178–676) NA
Diagnostic tests 3,006 (2,134–4,511) 1,536 (1,152–2,332) 701(536– 1,199) NA
Clinical services 616 (416–1,749) 426 (312–839) 140 (106–481) NA

             *Currency in US $, rounded to the nearest dollar. NA, not applicable.              †All costs pertaining to each category of visit.              ‡Cumulative cost divided by the duration of total follow-up in years.              §Cumulative cost for outpatients divided by the number of outpatient visits.              ¶Cumulative cost of admission divided by the number of admissions.

Main Article

1These first authors contributed equally to this article.

2These authors were co–principal investigators.

Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external